Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure

BACKGROUND: The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but data on long-term outcomes are limited. METHODS: For 4 years, we followed children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of RTS,S/AS01E vaccine (223 children) or rabies va...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Olotu, Ally, Fegan, Gregory, Wambua, Juliana, Nyangweso, George, Awuondo, Ken O., Leach, Amanda, Lievens, Marc, Leboulleux, Didier, Njuguna, Patricia, Peshu, Norbert, Marsh, Kevin, Bejon, Philip
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156295/
https://ncbi.nlm.nih.gov/pubmed/23514288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1207564
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars